Clinical Trials Matching Software Market Size to Reach USD 501.86 Million by 2032, Driven by AI and EHR Integration – SNS Insider [Yahoo! Finance]
Phreesia, Inc. (PHR)
Last phreesia, inc. earnings: 4/22 04:09 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
Austin, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Clinical Trials Matching Software Market Size & Growth Analysis According to SNS Insider, the global clinical-trials matching software market was valued at USD 187.14 million in 2024 and is expected to reach USD 501.86 million by 2032, growing at a compound annual growth rate (CAGR) of 13.14% from 2025 to 2032. The U.S. segment, valued at USD 74.78 million in 2024, is projected to hit USD 199.51 million by 2032, driven by advanced healthcare-IT infrastructure, rising clinical-trial volume, and deepening AI-enabled patient-matching applications. Demand for high-precision patient matching is growing because trials are more complex, eligibility criteria are tighter, and sponsors and contract research organizations (CROs) are under pressure to accelerate enrollment and boost trial efficiency. Leading platforms now integrate electronic health records (EHRs), deploy real-time eligibility screening and offer patient-facing channels that enhance
Show less
Read more
Impact Snapshot
Event Time:
PHR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PHR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PHR alerts
High impacting Phreesia, Inc. news events
Weekly update
A roundup of the hottest topics
PHR
News
- Phreesia's Megan Turco Named to MM+M 40 Under 40 [Yahoo! Finance]Yahoo! Finance
- Phreesia’s Megan Turco Named to MM+M 40 Under 40Business Wire
- Phreesia (NYSE:PHR) had its price target raised by analysts at DA Davidson from $33.00 to $35.00. They now have a "buy" rating on the stock.MarketBeat
- Phreesia (PHR) Earnings Expected to Grow: Should You Buy? [Yahoo! Finance]Yahoo! Finance
- Phreesia Named to the 2025 Deloitte Technology Fast 500™ [Yahoo! Finance]Yahoo! Finance
PHR
Earnings
- 9/4/25 - Beat
PHR
Sec Filings
- 11/13/25 - Form SCHEDULE
- 11/12/25 - Form 8-K
- 11/5/25 - Form SCHEDULE
- PHR's page on the SEC website